New Jersey regulators awarded 14 new medical cannabis business licenses in advance of next year’s likely adult-use market launch.
The issuance of the licenses fulfills a 2-year-old plan to expand the state’s MMJ program.
According to NJ.com, the state’s Cannabis Regulatory Commission on Friday announced the permit winners, a mixture of 10 cultivation and four manufacturing licenses.
All 14 licenses went to companies owned by minorities or women:
- Hillview Med
- GSCC Management
- NJ Nectar Ventures
- Noble Valley Harvest Co.
- Green Medicine NJ
- ZY Labs
- The NAR Group
- Bloom Medicinals of PA
- Garden State Releaf
- Etain NJ
- Altus New Jersey
- Holistic NJ
- Greenhouse Wellness of NJ
Key insights to inform decisions: MJBizFactbook
Say hello to marijuana business data, curated by the editors of MJBizDaily to help cannabis industry leaders make informed decisions.
- U.S. marijuana industry financials
- Licensing, funding and investment trends
- State-by-state guide to regulations, taxes and opportunities
- Insights for business and investment strategy
The expansion is a partial culmination of a plan that began in 2019 to expand New Jersey’s relatively small MMJ market, which currently has only 23 dispensaries to serve 117,000 registered patients in the state.
But the expansion was paused for a year and a half because of a lawsuit, which was finally resolved in February.
The commission will likely award even more licenses in coming weeks, NJ.com reported, since the original expansion plan called for 24 new MMJ licenses, including 15 dispensaries, five cultivators and four vertically integrated operations.
But the commission decided at the last minute Friday to double the number of cultivators to 10.
The commission also still must set a date for when adult-use sales might begin.